The BMO Canadian Dividend ETF is heavily concentrated in financials and energy, which represent nearly 60% of its holdings.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Dating in our modern world is hard. Between dating apps vs. meeting people organically, it can be hard to find someone you really hit it off with … especially in Vancouver. One of the latest plays by ...

Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...

Arvinas, Inc. (NASDAQ:ARVN – Get Free Report)’s share price reached a new 52-week low on Monday after Barclays lowered their price target on the stock from $48.00 to $32.00. Barclays currently has an ...

Royal Bank of Canada maintains a low nonperforming loans to total loans ratio, indicating quality loans. See why I rate RY ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

"Such an approval adds to the mounting body of evidence showing GLP-1 agents' utility in indications beyond type 2 diabetes and obesity," BMO Capital analyst Evan Seigerman said. The approval was ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with ...

Sprouts Farmers Market, Inc. (NASDAQ:SFM – Get Free Report) reached a new 52-week high on Thursday after Wells Fargo & Company raised their price target on the stock from $130.00 to $140.00. Wells ...

Brian Belski, BMO Capital Markets chief investment strategist ... see-through or ‘lewd’ clothing and ‘offensive’ body art Justin Baldoni releases unedited 'It Ends With Us' footage ...